Pro Share Advisors LLC Zoetis Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 205,576 shares of ZTS stock, worth $36.4 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

205,576

Previous 109,521 87.7%

Holding current value

$36.4 Million

Previous $19 Million 111.55%

% of portfolio

0.1%

Previous 0.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$172.58 - $196.48 $16.6 Million - $18.9 Million	96,055 Added 87.7%	205,576 $40.2 Million
Q2 2024 Aug 13, 2024	BUY	$145.54 - $178.83 $383,206 - $470,859	2,633 Added 2.46%	109,521 $19 Million
Q1 2024 May 08, 2024	SELL	$165.67 - $199.94 $387,833 - $468,059	-2,341 Reduced 2.14%	106,888 $18.1 Million
Q4 2023 Feb 14, 2024	SELL	$151.44 - $200.09 $1.58 Million - $2.09 Million	-10,421 Reduced 8.71%	109,229 $21.6 Million
Q3 2023 Nov 13, 2023	SELL	$167.14 - $192.77 $2.86 Million - $3.29 Million	-17,082 Reduced 12.49%	119,650 $20.8 Million
Q2 2023 Aug 10, 2023	SELL	$160.94 - $186.23 $233,684 - $270,405	-1,452 Reduced 1.05%	136,732 $23.5 Million
Q1 2023 May 11, 2023	BUY	$145.48 - $175.02 $9.88 Million - $11.9 Million	67,926 Added 96.68%	138,184 $23 Million
Q4 2022 Feb 02, 2023	SELL	$131.14 - $157.47 $399,976 - $480,283	-3,050 Reduced 4.16%	70,258 $10.3 Million
Q3 2022 Nov 04, 2022	SELL	$148.29 - $182.55 $1.2 Million - $1.48 Million	-8,086 Reduced 9.93%	73,308 $10.9 Million
Q2 2022 Aug 01, 2022	SELL	$155.97 - $200.09 $4.56 Million - $5.85 Million	-29,253 Reduced 26.44%	81,394 $14 Million
Q1 2022 May 10, 2022	SELL	$181.39 - $234.03 $469,618 - $605,903	-2,589 Reduced 2.29%	110,647 $20.9 Million
Q4 2021 Feb 08, 2022	BUY	$193.69 - $247.03 $4.44 Million - $5.66 Million	22,929 Added 25.39%	113,236 $27.6 Million
Q3 2021 Nov 12, 2021	SELL	$189.29 - $209.69 $435,934 - $482,916	-2,303 Reduced 2.49%	90,307 $17.5 Million
Q2 2021 Aug 13, 2021	BUY	$155.9 - $187.99 $2 Million - $2.41 Million	12,823 Added 16.07%	92,610 $17.3 Million
Q1 2021 May 14, 2021	BUY	$144.0 - $169.39 $432,144 - $508,339	3,001 Added 3.91%	79,787 $12.6 Million
Q4 2020 Feb 09, 2021	BUY	$157.07 - $174.35 $908,335 - $1.01 Million	5,783 Added 8.14%	76,786 $12.7 Million
Q3 2020 Nov 13, 2020	BUY	$137.1 - $165.37 $72,251 - $87,149	527 Added 0.75%	71,003 $11.7 Million
Q2 2020 Aug 03, 2020	BUY	$111.92 - $142.53 $98,937 - $125,996	884 Added 1.27%	70,476 $9.66 Million
Q1 2020 May 15, 2020	SELL	$92.66 - $144.94 $3.78 Million - $5.92 Million	-40,845 Reduced 36.98%	69,592 $8.19 Million
Q4 2019 Feb 12, 2020	BUY	$116.25 - $133.25 $1.66 Million - $1.9 Million	14,292 Added 14.87%	110,437 $14.6 Million
Q3 2019 Nov 12, 2019	BUY	$112.57 - $128.43 $146,341 - $166,959	1,300 Added 1.37%	96,145 $12 Million
Q2 2019 Aug 13, 2019	SELL	$97.98 - $114.28 $1.6 Million - $1.87 Million	-16,346 Reduced 14.7%	94,845 $10.8 Million
Q1 2019 May 15, 2019	BUY	$81.56 - $100.67 $274,694 - $339,056	3,368 Added 3.12%	111,191 $11.2 Million
Q4 2018 Feb 14, 2019	SELL	$79.28 - $95.27 $66,515 - $79,931	-839 Reduced 0.77%	107,823 $9.22 Million
Q3 2018 Nov 14, 2018	BUY	$83.5 - $93.23 $552,853 - $617,275	6,621 Added 6.49%	108,662 $9.95 Million
Q2 2018 Aug 13, 2018	SELL	$79.9 - $89.2 $400,618 - $447,248	-5,014 Reduced 4.68%	102,041 $8.69 Million
Q1 2018 May 14, 2018	BUY	$71.51 - $84.69 $296,337 - $350,955	4,144 Added 4.03%	107,055 $8.94 Million
Q4 2017 Feb 14, 2018	BUY	$63.24 - $72.8 $1.51 Million - $1.74 Million	23,849 Added 30.16%	102,911 $7.41 Million
Q3 2017 Nov 13, 2017	BUY	$59.73 - $65.4 $421,514 - $461,527	7,057 Added 9.8%	79,062 $5.04 Million
Q2 2017 Aug 11, 2017	BUY	N/A	72,005	72,005 $4.49 Million

Others Institutions Holding ZTS

# of Institutions

1,956

Shares Held

412M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Zoetis Inc. Transaction History